Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Science Immunology
|
November 22, 2024
GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing
Jacki E Heraud-Farlow, Scott R Taylor, Alistair M Chalk, et al.
Scientific Reports
|
May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
Hui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Cell Reports
|
August 3, 2025
Core fucosylation of IL-2RB is required for natural killer cell homeostasis
Harrison Sudholz, Xiangpeng Meng, Hae-Young Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2022
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2024
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Breast Cancer Research : BCR
|
June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
Yu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Cancer Cell
|
June 13, 2025
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling
Iva Nikolic, Joseph Cursons, Benjamin Shields, et al.
Blood
|
February 7, 2013
EGFL7 ligates αvβ3 integrin to enhance vessel formation
Iva Nikolic, Nevenka Dudvarski Stankovic, Frank Bicker, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer
Sarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Nature Communications
|
March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype
Simon Junankar, Laura A Baker, Daniel L Roden, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Science Immunology
|
November 22, 2024
GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing
Jacki E Heraud-Farlow, Scott R Taylor, Alistair M Chalk, et al.
Scientific Reports
|
May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
Hui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Cell Reports
|
August 3, 2025
Core fucosylation of IL-2RB is required for natural killer cell homeostasis
Harrison Sudholz, Xiangpeng Meng, Hae-Young Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2022
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2024
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Breast Cancer Research : BCR
|
June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
Yu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Cancer Cell
|
June 13, 2025
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling
Iva Nikolic, Joseph Cursons, Benjamin Shields, et al.
Blood
|
February 7, 2013
EGFL7 ligates αvβ3 integrin to enhance vessel formation
Iva Nikolic, Nevenka Dudvarski Stankovic, Frank Bicker, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer
Sarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Nature Communications
|
March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype
Simon Junankar, Laura A Baker, Daniel L Roden, et al.
Page
of 3